Patents by Inventor René Lattmann

René Lattmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZO PYRIDINE DERIVATIVES
    Publication number: 20090291942
    Abstract: The invention relates to novel imidazopyridine derivatives and to their use in the treatment of diseases and disorders which may e.g. involve angiogenesis and/or pain, including autoimmune and inflammatory diseases.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 26, 2009
    Inventors: Ivan Cornella Taracido, Edmund Martin Harrington, René Hersperger, René Lattmann, Wolfgang Miltz, Klaus Weigand
  • Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
    Patent number: 6723742
    Abstract: The use is described of 3,5-diphenyl-1,2,4-triazoles of the formula I in which R1-R5 are as defined in the description. The compounds have useful pharmaceutical properties and are particularly active as iron chelators. They can be used for the treatment of iron overload in warm-blooded animals.
    Type: Grant
    Filed: May 29, 2003
    Date of Patent: April 20, 2004
    Assignee: Novartis AG.
    Inventors: René Lattmann, Pierre Acklin
  • Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
    Patent number: 6596750
    Abstract: The use is described of 3,5-diphenyl-1,2,4-triazoles of the formula I in which R1-R5 are as defined in the description. The compounds have useful pharmaceutical properties and are particularly active as iron chelators. They can be used for the treatment of iron overload in warm-blooded animals.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: July 22, 2003
    Assignee: Novartis AG
    Inventors: René Lattmann, Pierre Acklin
  • Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
    Patent number: 6465504
    Abstract: The use is described of 3,5-diphenyl-1,2,4-triazoles of the formula I in which R1-R5 are as defined in the description. The compounds have useful pharmaceutical properties and are particularly active as iron chelators. They can be used for the treatment of iron overload in warm-blooded animals.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: October 15, 2002
    Assignee: Novartis AG
    Inventors: René Lattmann, Pierre Acklin